Hepatitis B and C virus (HBV), (HBC) infection is a major public health problem worldwide, that endangers patients' lives, resulting in serious health consequences due to clinical comorbidities such as liver cirrhosis and hepatocellular carcinoma. Even though accessible resources for vaccination, testing, and therapeutic interventions, the incidence of HBV in hemodialysis remains crucial. The study aimed to detect HBsAg and anti-HCV in HD patients and the control group. In a retrospective case-control, the hospital-based study was carried out on 110 participants 60 HD patients and 50 control, ELISA method was used to detect HBsAg and anti-HCV in HD patients and control sera. The prevalence rate of HBV infection was 26.3%, among HD patients, and the control group was 45 %, and 4% respectively. While the overall prevalence of HCV was 1,8 % and it was 3.3% among the HD patients, there were no cases of HBC infection among the healthy group. A statistically significant correlation between HBV infection and HD was revealed (P-value 0.019). The prevalence of HBV was extremely high among HD patients. The findings highlight the importance of performing a constructive intervention for rapid identification, and diagnosis using PCR technique, also therapeutic interventions of infected patients, and vaccination of those with non-protective anti-HBs antibodies, in an attempt to reduce morbidity and mortality in HD patients.
1. Ali N, Hussain W, Hayat A, Shah T, Wen R, Zeb I, et al. Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients: a multicentric study. Eur J Gastroenterol Hepatol. 2019;31(1):29-33.
2. Akazong EW, Tume C, Ayong L, Njouom R, Kenmoe S, Njankouo R, et al. Cross-sectional hospital-based study on the seroprevalence of hepatitis B virus markers among healthcare workers, NWR, Cameroon. BMJ Open. 2021;11(7):e045716. doi:10.1136/bmjopen-2020-045716
3. D'souza S, Lau KC, Coffin CS, Patel TR. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol. 2020;26(38):5759-83.
4. Gasim GI, Hamdan HZ, Hamdan SZ, Adam I. Epidemiology of hepatitis B and hepatitis C virus infections among hemodialysis patients in Khartoum, Sudan. J Med Virol. 2012;84(1):52-5.
5. Yuen MF, Chen DS, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA, et al. Hepatitis B virus infection. Nat Rev Dis Primers. 2018;4(1):18035.
6. Okui T, Nakashima N. Analysis of the association between areal socioeconomic deprivation levels and viral hepatitis B and C infections in Japanese municipalities. BMC Public Health. 2022;22(1):681. doi:10.1186/s12889-022-13089-w
7. Simula MP, Caggiari L, Gloghini A, De Re V. HCV-related immunocytoma and type II mixed cryoglobulinemia-associated autoantigens. Ann N Y Acad Sci. 2007;1110(1):121-30.
8. Manns MP, Buti M, Gane E, Pawlotsky JM, Razavi H, Terrault N, et al. Hepatitis C virus infection. Nat Rev Dis Primers. 2017;3(2):17006.
9. Borgia SM, Hedskog C, Parhy B, Hyland RH, Stamm LM, Brainard DM, et al. Identification of a Novel Hepatitis C Virus Genotype from Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes. J Infect Dis. 2018;218(11):1722-9.
10. Bravo Zuñiga JI, Loza Munárriz C, López-Alcalde J. Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units. Cochrane Database Syst Rev. 2016;(8):78.
11. Bernieh B. Viral hepatitis in hemodialysis: An update. J Transl Int Med. 2015;3(3):93105.
12. Savoy ML. Hepatitis B (HepB) Vaccine. Lewis Katz School of Medicine at Temple University. 2021.
13. Gasim GI, Hamdan HZ, Hamdan SZ, Adam I. Epidemiology of hepatitis B and hepatitis C virus infections among hemodialysis patients in Khartoum, Sudan. J Med Virol. 2012;84(1):52-5.
14. Mudawi HM. Epidemiology of viral hepatitis in Sudan. Clin Exp Gastroenterol. 2008;1:9-13. doi:10.2147/ceg.s3887
15. Saravanan S, Velu V, Nandakumar S, Madhavan V, Shanmugasundaram U, Murugavel KG, et al. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease. J Microbiol Immunol Infect. 2009;42(2):122-8.
16. Malyszko J, Zawierucha J, Marcinkowski W, Prystacki T, Dryl-Rydzynska T, Malyszko JS, et al. The prevalence of hepatitis C and B among patients on hemodialysis and on renal transplantation waiting list in Poland has significantly decreased during the last 10 years. Int Urol Nephrol. 2018;50(8):1555-6.
17. Bernieh B. Viral hepatitis in hemodialysis: An update. J Transl Int Med. 2015;3(3):93-105.
18. Chaabna K, Kouyoumjian SP, Abu-Raddad LJ. Hepatitis C virus epidemiology in Djibouti, Somalia, Sudan, and Yemen: systematic review and meta-analysis. PloS one. 2016;11(2):e0149966.
19. Hammad MA, ALLA M, Salih RA. Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections among hemodialysis patients at OMTH. Eur J Pharm Med Res. 2016;3:108-1.
20. Emad-Aldin IO, Nagwa AA, Osman A, Waleed HO, Hafi AS, Muzamil MA. Prevalence of Hepatitis B surface antigen and Hepatitis C virus antibodies among pre-surgery screened patients in Khartoum, Central Sudan. J Gen Mol Virol. 2012;4(1):6-9.
21. Malhotra R, Soin D, Grover P, Galhotra S, Khutan H, Kaur N. Hepatitis B virus and hepatitis C virus co-infection in hemodialysis patients: A retrospective study from a tertiary care hospital of North India. J Nat Sci Boil Med. 2016;7(1):72.
Copyright © 2024 Archives of Pharmacy Practice. Authors retain copyright of their article if they are accepted for publication.
Developed by Archives of Pharmacy Practice
